DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease: A mini review

O. Maeda, T. Ando, O. Watanabe, K. Ishiguro, Naoki Omiya, Y. Niwa, H. Goto

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

DNA hypermethylation is one of major epigenetic changes. Hypermethylation of many genes has been reported to be related with carcinogenesis and tumor progression of colorectal cancer. Some genes including estrogen receptor is associated with ageing, and changes related with ageing may be accelerated in inflammatory bowel disease. Furthermore, fecal DNA methylation will be able to be used as a marker of colorectal cancer and inflammatory bowel disease. Evaluation of hypermethylation potentially contributes diagnosis of colorectal diseases.

Original languageEnglish
Pages (from-to)204-206
Number of pages3
JournalInflammopharmacology
Volume14
Issue number5-6
DOIs
Publication statusPublished - 01-12-2006
Externally publishedYes

Fingerprint

Inflammatory Bowel Diseases
Colorectal Neoplasms
DNA
DNA Methylation
Epigenomics
Estrogen Receptors
Genes
Carcinogenesis
Neoplasms

All Science Journal Classification (ASJC) codes

  • Immunology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Maeda, O. ; Ando, T. ; Watanabe, O. ; Ishiguro, K. ; Omiya, Naoki ; Niwa, Y. ; Goto, H. / DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease : A mini review. In: Inflammopharmacology. 2006 ; Vol. 14, No. 5-6. pp. 204-206.
@article{1f5068ba9c5e40acb0d96225b043972c,
title = "DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease: A mini review",
abstract = "DNA hypermethylation is one of major epigenetic changes. Hypermethylation of many genes has been reported to be related with carcinogenesis and tumor progression of colorectal cancer. Some genes including estrogen receptor is associated with ageing, and changes related with ageing may be accelerated in inflammatory bowel disease. Furthermore, fecal DNA methylation will be able to be used as a marker of colorectal cancer and inflammatory bowel disease. Evaluation of hypermethylation potentially contributes diagnosis of colorectal diseases.",
author = "O. Maeda and T. Ando and O. Watanabe and K. Ishiguro and Naoki Omiya and Y. Niwa and H. Goto",
year = "2006",
month = "12",
day = "1",
doi = "10.1007/s10787-006-1540-6",
language = "English",
volume = "14",
pages = "204--206",
journal = "Inflammopharmacology",
issn = "0925-4692",
publisher = "Birkhauser Verlag Basel",
number = "5-6",

}

DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease : A mini review. / Maeda, O.; Ando, T.; Watanabe, O.; Ishiguro, K.; Omiya, Naoki; Niwa, Y.; Goto, H.

In: Inflammopharmacology, Vol. 14, No. 5-6, 01.12.2006, p. 204-206.

Research output: Contribution to journalArticle

TY - JOUR

T1 - DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease

T2 - A mini review

AU - Maeda, O.

AU - Ando, T.

AU - Watanabe, O.

AU - Ishiguro, K.

AU - Omiya, Naoki

AU - Niwa, Y.

AU - Goto, H.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - DNA hypermethylation is one of major epigenetic changes. Hypermethylation of many genes has been reported to be related with carcinogenesis and tumor progression of colorectal cancer. Some genes including estrogen receptor is associated with ageing, and changes related with ageing may be accelerated in inflammatory bowel disease. Furthermore, fecal DNA methylation will be able to be used as a marker of colorectal cancer and inflammatory bowel disease. Evaluation of hypermethylation potentially contributes diagnosis of colorectal diseases.

AB - DNA hypermethylation is one of major epigenetic changes. Hypermethylation of many genes has been reported to be related with carcinogenesis and tumor progression of colorectal cancer. Some genes including estrogen receptor is associated with ageing, and changes related with ageing may be accelerated in inflammatory bowel disease. Furthermore, fecal DNA methylation will be able to be used as a marker of colorectal cancer and inflammatory bowel disease. Evaluation of hypermethylation potentially contributes diagnosis of colorectal diseases.

UR - http://www.scopus.com/inward/record.url?scp=33845890020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845890020&partnerID=8YFLogxK

U2 - 10.1007/s10787-006-1540-6

DO - 10.1007/s10787-006-1540-6

M3 - Article

C2 - 17093903

AN - SCOPUS:33845890020

VL - 14

SP - 204

EP - 206

JO - Inflammopharmacology

JF - Inflammopharmacology

SN - 0925-4692

IS - 5-6

ER -